Orsight Pharma
Neovascular Age-Related Macular Degeneration Drug Treatment
Startup · IsraelOrsight Pharma is a Nazareth-based startup in the Health Tech & Life Sciences sector, established in 2023. Neovascular Age-Related Macular Degeneration Drug Treatment. The company has raised a total of $2.1M across 2 funding rounds, currently at the Pre-Seed stage. Orsight Pharma was founded by Mariana Truman. The company has 1-10 employees.
With $2.1M in total funding, Orsight Pharma is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2C business model. Product stage: R&D.
- StagePre-Seed
- ProductR&D
- ModelB2C
- Employees1-10
- HQNazareth
- DistrictNorth District
- Last RoundUndisclosed
Mariana TrumanCo-founder & CTO
What does Orsight Pharma do?
Orsight Pharma develops a breakthrough small molecule treatment designed to preserve vision and prevent blindness through a novel VEGF-independent mechanism. This drug offers a ray of hope, especially for those who have not seen satisfactory results with existing treatments. The company's product not only stands to benefit patients unresponsive to current therapies but also has the potential to enhance visual outcomes when used in combination with them.
How much funding has Orsight Pharma raised?
Orsight Pharma has raised $2.1M in total funding across 2 rounds. The company is currently at the Pre-Seed stage.
Who founded Orsight Pharma?
Orsight Pharma was founded in 2023 by Mariana Truman (Co-founder & CTO).
What sector is Orsight Pharma in?
Orsight Pharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development.
Where is Orsight Pharma located?
Orsight Pharma is based in Nazareth, Israel, North District.